5T4 and CD137 modulator therapy(Crescendo Biologics)

N/A

Report date: 2024/04/19 15:02:41

Base Information

Drug Name5T4 and CD137 modulator therapy(Crescendo Biologics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionTrophoblast glycoprotein modulatorsTumor necrosis factor receptor superfamily member 9 modulators
TargetsTrophoblast glycoproteinTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrescendo Biologics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCrescendo Biologics Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A